Companies › GH
GUARDANT HEALTH INC (GH)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001576280 · EDGAR filings · Updated 2026-07-28
GUARDANT HEALTH INC (GH) has reported institutional ownership of 103.6%, with 482 institutional managers holding positions valued at $12.5B per the latest 13F reporting period.
Filings this week (2)
- 2026-07-28 — SCHEDULE 13G/A filed
- 2026-07-22 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-20 — Insider transaction reported (Form 4)
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-16 — Notice of proposed sale filed (Form 144)
- 2026-07-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, GUARDANT HEALTH INC has 482 institutional holders and institutional ownership of 103.6%.
Insider activity
Insiders reported 398 transactions (0 buys, 98 sells) across 18 reporting insiders, with a net reported value of −$87.1M.
Related companies
NEUROCRINE BIOSCIENCES INC (NBIX) · ELANCO ANIMAL HEALTH INC (ELAN) · IONIS PHARMACEUTICALS INC (IONS) · ASCENDIS PHARMA A/S SPONSORED (ASND) · MADRIGAL PHARMACEUTICALS INC (MDGL) · JAZZ PHARMACEUTICALS PLC (JAZZ)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.